Scottsdale, Ariz. (July 29, 2025) – HonorHealth, a leading Valley healthcare system serving more than five million people in the greater Phoenix area, has launched its Artificial Heart Program, following accreditation by DNV in March 2025. This milestone marks a major advancement in treating advanced heart failure, bringing lifesaving durable mechanical circulatory support to patients across Arizona and the Southwest.
Heart failure affects nearly 6.7 million U.S. adults and is expected to rise to 8 million by 2030. In advanced stages, it can mean frequent hospital visits, extreme fatigue, and a much shorter life expectancy. With the introduction of cutting-edge Ventricular Assist Device (VAD) technology, HonorHealth now provides a critical option for patients whose hearts can no longer pump enough blood on their own.
The program utilizes specialists across many disciplines collaborating to support patients and their families every step of the way with knowledge, compassion and a clear plan to navigate heart failure with confidence and hope.
Learn more about the HonorHealth Artificial Heart Program.